GLP Watchdog

SkinnyRx vs SnagRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. SnagRx has none. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

SkinnyRx / SnagRx

SkinnyRx logo

SkinnyRx

6.3/10

SnagRx logo

SnagRx

9.2/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$248/moBrand-name semaglutide pill
$99/moCompounded semaglutide injection
States
47 states
49 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit SkinnyRx
Visit SnagRx

Both SkinnyRx and SnagRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (SkinnyRx 6.3, SnagRx 9.2). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. SnagRx has none.

  2. 02

    SnagRx names four pharmacies. SkinnyRx names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

  4. 04

    Only SkinnyRx lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.

  5. 05

    SnagRx covers two states SkinnyRx does not.

  6. 06

    SkinnyRx states you can cancel at any time; SnagRx does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

SkinnyRx

SnagRx

Compounded semaglutide injection

$99/mo

first month only; not compared

$99/mo

$1,188 a year

Compounded tirzepatide injection

$99/mo

first month only; not compared

$149/mo

$1,788 a year

Brand-name semaglutide pen

$1,400/mo

$16,800 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,400/mo

$16,800 a year

Not sold or not priced
Compounded oral semaglutide

$149/mo

first month only; not compared

Not sold or not priced
Compounded oral tirzepatide

$199/mo

first month only; not compared

Not sold or not priced
Brand-name semaglutide pill

$248/mo

$2,976 a year

Not sold or not priced
Foundayo (orforglipron) pill

$248/mo

$2,976 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Not stated
Minimum term
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Not stated
Refunds
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods
Not stated

Read off each seller’s own pages. SkinnyRx: October 30, 2026. SnagRx: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for SkinnyRx

6.3/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which SnagRx does not price
  • States you can cancel at any time
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

The case for SnagRx

9.2/10
  • No FDA warning letter on record
  • Names its compounding pharmacy
Visit SnagRx

Scores

SkinnyRx 6.3 · SnagRx 9.2 out of 10. Six weighted parts.

Value25%

5.6A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

2.0A
vs
B
9.0

Accessibility10%

9.5A
vs
B
9.8

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

SkinnyRx vs SnagRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. SnagRx has none. Letters are matched to a seller by company, domain and address, never by a similar name.
SnagRx names four pharmacies. SkinnyRx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods. SnagRx does not state its cancellation terms.
Both SkinnyRx and SnagRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (SkinnyRx 6.3, SnagRx 9.2).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks